| Literature DB >> 35910230 |
Azka Noureen1,2, Muhammad Zuhaib Khan1, Imran Amin1, Tayyaba Zainab2,3, Shahid Mansoor1.
Abstract
Potato (Solanum tuberosum L.) is an important staple food around the world, and potato virus Y (PVY) is a major constraint for potato production. The VPg protein of PVY interacts with the translation initiation factor eIF4E of the host that works as a susceptibility factor during infection. The interaction between eIF4E and VPg was disrupted by CRISPR/Cas9. The homozygous conserved region of eIF4E of the potato variety "Kruda" was mutated by CRISPR/Cas9. Tracking of insertion, deletion, and conversion events was performed by Sanger sequencing with ∼15% editing efficiency. Truncated and mutated eIF4E proteins were unable to interact with VPg, and the virus was not able to exploit the host machinery for replication and systemic spreading. Mutated eIF4E lines showed enhanced resistance to PVYO strain. DAS-ELISA and RT-PCR were used for validation of the observed resistance. PVY resistance in tetraploid lines via CRISPR/Cas9 provides a route to develop novel resistant potato cultivars.Entities:
Keywords: CRISPR-Cas9; DAS-ELISA; PVY; RT-PCR; VPg-EIF4E protein interaction; eIF4E; potato viruses
Year: 2022 PMID: 35910230 PMCID: PMC9326172 DOI: 10.3389/fgene.2022.922019
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.772
eIF4E gRNA sequences.
| Gene | sgRNA | Sequence |
|---|---|---|
|
| F | 5′ATTGTGATGCAGCTGAGAAGTTGA 3′ |
| R | 5′AAACTCAACTTCTCAGCTGCATCA 3′ | |
|
| F | 5′ATTGCGCCGATGGAGGAGGAGGGG 3′ |
| R | 5′AAACCCCCTCCTCCTCCATCGGCG 3′ |
FIGURE 1(A) Amplification of eIF4E gene and the 4.5-kb fragment; (B) amplification using the PCF/PCR primer set and the 556-bp fragment; (C) confirmation of gRNA in each construct by restriction analysis with the Bbs1 site in p. chimera vector; (D) the gRNA cassette confirmation in the Pk2GW7-Cas9 vector (uncropped gel pictures with +ve and −ve controls are present in Supplementary Figures S4A–C); (E) pK2GW7E1;; (F) pk2GW7E2 through Sanger sequence confirmation of the gRNA cassette; (G) schematic diagram of the construct used for genome editing. All gRNAs targeting eIF4E were cloned in the same manner. The construct was expressing gRNA under the At-U6 promoter. The plant codon-optimized Cas9 was expressed under the 35S CaMV promoter.
FIGURE 2(A) Callus induction and development stage; (B) callus development and selection; (C) callus growth; (D) shooting stage; (E–G) shoot and root growth; (H) plants shifted to the glass house.
Editing events confirmation at allelic base through Sanger sequencing.
| Line | Wild-type | Sequences (5′…….3′) | Editing event |
|---|---|---|---|
| Wild-type | ATGGCAGCAGCTGAAATGGAGAGAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATGGA | ||
| E1.8 | Allele 1 | ATGGCAGCAGCTGAAATGGAGAGAACGACCTCGTTTGATGCAGCTGA-AAGTTGAAGGCCGACGATGGA | 0 |
| Allele 2 | ATGGCAGCAGCTGAAATGGAGAGAACGACCTCGTTTGATGCAGCTGA-AAGTTGA AGGCCGACGATGGA | 0 | |
| Allele 3 | ATGGCAGCAGCTGAA-TGGAGAGAA ACGACCTCGTTTGATGCG/CGCTGA-AAAGTTGAAGGCCGACGAG | −1 bp Substitution −1 bp, +1 bp | |
| Allele 4 | ATGGCAGCAGCTGAAATGGAGAGAACGACCTCCTTTGATGCAGCTGA-----AGTTGAAGGCCGACGATGGA | −1 | |
| E1.9 | Allele 1 | ATGGCAGCAGCTGAAATGGAGAGAACGACGTCGTTTGATGCAGCTGAGAAAG-GAAGGCCGACGATGGA | −1 bp |
| Allele 2 | ATGGCAGCAGCTGAAATGGAGAGAACGACGTCGTTTGATGCAGCTGAG--AGTTGAAGGCCGACGATGGA | −2 bp | |
| Allele 3 | ATGGCAGCAGCTGAAATGGAGAGAACGACGTCGTTTGA---CAGCTGAGAAGTTGAAGGCCGACGATGGAG | −1 bp | |
| Allele 4 | ATGGCAGCAGCTGAAATGGAGAGAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGACGATGGA | 0 bp | |
| E1.16 | Allele 1 | ATGGCCGCAGCTGAAATGGAGACGAA-GGAGCATATA------------------------------- ----------------GATGGAG | −25/+10 bp |
| Allele 2 | ATGG-AGAG--AACGACGAGGA---GCATATATAGGTGAGGGAAGAGAGCATATATGGAGACTTTCCAGATC | −15 bp/+14 bp | |
| Allele 3 | ATGGAGAGAACGACGAGG-AGCATATATATAGGTGAGGGGAAGAGAGCATATATGGAGAGACTTTCCAA | −25 bp/+35 bp | |
| Allele 4 | ATGGCAGCAGCTGAAATGGAGAGAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATGGA | 0 bp | |
| E1.46 | Allele 1 | ATGGAGAGAACGACG----- ---------------CCGCATATCT---------------- CATCCATTGGAGCATTCATGGACTTT | −139 bp/+42 bp |
| Allele 2 | ATGGCAGCAGCTGAAATGGAGAGAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGACGATGGA | 0 bp | |
| Allele 3 | ATGGCAGCAGCTGAA-TGGAGAGAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATGGAG | −1 bp (stop codon) | |
| Allele 4 | ATGGCAGCAGCTGAA-TGGAGAGAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATGGA | -1 bp (stop codon) | |
| Wild-type | GAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATGGAGGAGGAGGGGAGGTAGACGATG | ||
| E2.9 | Allele 1 | GAACGACGTCGT-TGATGCAGCTGAGAAGTTGAAGGCCGCCGATGGAGGAGGAGGGGAGGTAGACGATG | −1 bp |
| Allele 2 | GAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATGCAGGAGGAGGAGAGGTAGACGATG | 2 bp substitutions | |
| Allele 3 | GAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATGG---AGGAGGGGAGGTAGACGATG | −3 bp | |
| Allele 4 | GAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATGCAGGAGGAGGAGAGGTAGACGAT | 2 bp substitutions | |
| E2.13 | Allele 1 | GAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATGGAGGAGGAGGGGAGGTAGACGATG | 0 bp |
| Allele 2 | GAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATGCAGGAGGAGGGGAGGTAGACGATG | 1 bp substitutions | |
| Allele 3 | GAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGGCCGCCGATG---GAGGAGGGGAGGTAGACGATG | −3 bp | |
| Allele 4 | GAACGACGTCGTTTGATGCAGCTGAGAAGTTGAAGCGCCGATGCAGGAGGAGGGGAGGTAGACGATG | −2 bp |
FIGURE 3PVY Inoculation and symptoms appearance on control and mutated lines. (A) Inoculation of PVY into the control plant; (B) virus mosaic pattern appearance on the control plant at 45 dpi; lines (C) K_E1.8, (D) K_E1.9, (E) K_E1.16, and (F) K_E1.46 showing strong resistance, and lines (G) K_E2.9 and (H) K_E2.13 showing tolerance against PVY. (I) Determination of PVY titer using DAS-ELISA; The assay was performed to check the PVY titer at regular intervals of 7, 15, 30, and 60 dpi. The control lines showed high titer, while the mutated eIF4E lines K_E1.8, K_E1.9, K_E1.16, K_E1.46, K_E2.9, and K_E2.13 showed virus titer only after 60 days, which was lower than all others.
Primers sequences used in RT-PCR.
| Name | Sequence |
|---|---|
| St Actin1 | St-AcF1: 5′GATGGCAGACGGAGAGGA3′ |
| St-AcR1: 5′GAGGACAGGATGCTCCTC3′ | |
| St Actin2 | St-AcF2: 5′GTGACAATGGAACTGGAATGGTCAAGGTAA3′ |
| St-AcR2: 5′GACCCATACCCACCATCACACCAGTATGGC3′ | |
|
| 5′ ATGGCAGCAGCTGAAATGGAGAGAACGAC3′ |
| 5′ AGTGAGCTTCCCCAAGCAGTTTGTCGAG3′ | |
| Cas9 (RT-F&RT-R) | 5′ GGACTCCCGGATGAACACTA3′ |
| 5′ TCGCTTTCCAGCTTAGGGTA3′ | |
| VPg (RT-vp1&2) | 5′GAATTCAAGCCTTGAAGTTTCGCCATGC3′ |
| 5′TGCGCCCCAGTGAGTGGATCAACGAATT3′ |
FIGURE 4(A); RNA-isolation. (B,C): Stranded amplification curve for titre determination. (C); The relative expression of Cas9 in mutated lines (E1.8, E1.9, E1.16, E1.46, E2.9, E2.13) with wild-type control. (D); The relative expression of Cas9 gene in mutated lines (E1.8, E1.9, E1.16, E1.46, E2.9, E2.13) (E); The relative expression of eIF4E gene in mutated lines (E1.8, E1.9, E1.16, E1.46, E2.9, E2.13) with wild-type control. (F): The absolute quantification of viral accumulation in mutated lines and wild-type susceptible control line after regular interval of 15dpi, 30dpi.
Serial dilution of plasmid.
| S. no. | Standard | Concentration (ng/µl) | Concentration in scientific notation | Copy number |
|---|---|---|---|---|
| 1 | S2 | 0.05 | 5.000E-02 | 2.3.E+08 |
| 2 | S3 | 0.005 | 5.000E-03 | 2.3.E+07 |
| 3 | S4 | 0.0005 | 5.000E-04 | 2.3.E+06 |
| 4 | S5 | 0.00005 | 5.000E-05 | 2.3.E+05 |
| 5 | S6 | 0.000005 | 5.000E-06 | 2.3.E+04 |
| 6 | S7 | 0.0000005 | 5.000E-07 | 2.3.E+03 |
FIGURE 5(A) Positive interaction of eIF4E protein of potato and VPg of PVY. (B) Genome editing efficiency of CRISPR/Cas and how it mutates the eIF4E and blocks the VPg–eIF4E interaction.
Primers sequences.
| Primers | Name | Sequence |
|---|---|---|
| P1 | Eif4-F | 5′ATGGCAGCAGCTGAAATGGAGAGAACGAC3′ |
| Eif4-R | 5′CTATACGGTGTAACGATTCTTGGCACTTCTG3′ | |
| P2 | PCF | 5′TCCAAAGCTTCCTAGGCTTTTTTTCTTC 3′ |
| PCR | 5′CCAGAAGCTTCTAGGTAATGCCAACTTT 3′ | |
| P3 | CasD F | 5′GCAAGAAATTCAAGGTGCTGGGCAACA3′ |
| CasD R | 5′ACTCTTCCAGTCTGTGGAAGAAGCTGT3′ | |
| P4 | PVYVpg-F | 5′GTGTCTCATCAAGGGAAAAATAAATCC3′ |
| PVYvpg-R | 5′AAGCCTCTCATGAGCGATTTAGCTTCAT3′ | |
| P5 | EF1 | 5′ATGGCAGCAGCTGAAATGGAGAGAACGAC3′ |
| ER1 | 5′ AGTGAGCTTCCCCAAGCAGTTTGTCGAG3′ | |
| P6 | KF | 5′GCACGAGGAAGCGGTCAGCCCATTCGCC3′ |
| KR | 5′AGACCGACCTGTCCGGTGCCCTGAATGAAC3′ |